drugset / Trial / NCT04481750

Study of Oral Edaravone in Healthy Adult Males

NCT04481750

Phase 1 Completed 74 enrolled Shionogi
RandomizedParallel-groupSingle-blindOther

Summary

To evaluate the pharmacokinetics safety, and tolerability of single and multiple doses of edaravone solution and suspension in healthy adult males

Timeline

Start
2018-03-20
Primary completion
2018-08-03
Completion
2018-08-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Edaravone Unknown Oral

Indications

No indication recorded.